Neuroendocrine tumors
Clinical trials for Neuroendocrine tumors explained in plain language.
Never miss a new study
Get alerted when new Neuroendocrine tumors trials appear
Sign up with your email to follow new studies for Neuroendocrine tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug entinostat studied for rare abdominal cancer, trial halted early
Disease control Stopped earlyThis study tested a drug called entinostat in people with advanced abdominal neuroendocrine tumors that had come back or stopped responding to other treatments. Only 5 people enrolled before the trial was stopped early. The goal was to see if the drug could shrink tumors or slow …
Matched conditions: NEUROENDOCRINE TUMORS
Phase 2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Promising cancer drug trial halted after just one patient
Disease control Stopped earlyThis study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …
Matched conditions: NEUROENDOCRINE TUMORS
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a sharper PET tracer light up hidden neuroendocrine tumors?
Diagnosis Stopped earlyThis trial tests an injected tracer called Gallium-68 HA-DOTATATE, which binds to somatostatin receptors found on most neuroendocrine tumors. Researchers want to see if a PET/CT or PET/MRI scan using this tracer is safe and accurately detects these tumors compared with standard C…
Matched conditions: NEUROENDOCRINE TUMORS
Phase 1/2 • Sponsor: AHS Cancer Control Alberta • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Swiss registry aims to map rare neuroendocrine tumors
Knowledge-focused Stopped earlyNeuroendocrine tumors of the gut and pancreas are rare and not well understood, which makes treatment decisions hard. The SwissNET registry collects health information from patients across Switzerland who have these tumors. Researchers will track tumor types, treatments used, and…
Matched conditions: NEUROENDOCRINE TUMORS
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC